Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04417842 · ClinicalTrials.gov registry record
Connect Lung Outcomes With Bronchodilator Use
A clinical trial, sponsored by Pulmonary Critical Care Associates of Baltimore.
- Completed
- Registry status
- 30
- Enrollment target
NCT04417842 is a clinical trial that has completed, run by Pulmonary Critical Care Associates of Baltimore. The registered enrollment target is 30 participants.
The verdict
NCT04417842 has completed, sponsored by Pulmonary Critical Care Associates of Baltimore.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
To determine the accuracy of the Respimetrix flow-volume monitoring device in measuring the patient's inspiratory capacity as compared to gold-standard measurements of inspiratory capacity on pulmonary function testing. Accuracy will be assessed before and after (A) pulmonary function testing and before and after (B) the administration of an inhaled bronchodilator medication.
Interventions
- DIAGNOSTIC_TEST Respimetrix flow-volume monitoring device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-08-27 |
| Est. Completion | 2022-04-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04417842
The ClinicalTrials.gov registry entry for NCT04417842 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pulmonary Critical Care Associates of Baltimore, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Respimetrix flow-volume monitoring device is the first listed.
NCT04417842 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04417842 about?
NCT04417842 is a clinical study titled "Connect Lung Outcomes With Bronchodilator Use". To determine the accuracy of the Respimetrix flow-volume monitoring device in measuring the patient's inspiratory capacity as compared to gold-standard measurements of inspiratory capacity on pulmonary function testing. Accuracy will be assessed before and after (A) pulmonary function testing and be...
What is the current status of trial NCT04417842?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2020-08-27. Estimated completion is 2022-04-25.
What interventions are being tested in trial NCT04417842?
The interventions under investigation include: Respimetrix flow-volume monitoring device (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04417842?
This trial is sponsored by Pulmonary Critical Care Associates of Baltimore, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.